ArticleACS omega2026
Ensemble Docking and Molecular Dynamics Indicate Dynamic Modulation of hnRNPA1 UP1 Interdomain Behavior by Natural Products.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
RNA-binding proteins exhibit substantial conformational plasticity that complicates structure-based ligand discovery and computational characterization. In this study, we applied an integrated computational approach combining high-throughput virtual screening, molecular dynamics simulations, ensemble docking, and interaction energy analysis to examine ligand binding and associated dynamic effects in the UP1 domain of hnRNPA1. Screening of 2847 phytochemicals followed by scaffold-diverse molecular dynamics evaluation identified three representative ligandsAmentoflavone, Ginkgetin, and Withanolide Dcapable of associating with the interdomain surface formed between the two RNA recognition motifs. Comparative simulations revealed that all three ligands form stable complexes within this region, with Ginkgetin exhibiting the most favorable interaction energy. Extended molecular dynamics simulations focusing on Withanolide D demonstrated persistent ligand localization at the RRM1-RRM2 interface and revealed a dominant interaction hotspot centered on SER85 and ARG86. Dynamic analyses indicated that RNA binding is the primary determinant of UP1 conformational stability, whereas ligand association induces modest conformational expansion and redistribution of dynamic variance within the RNA-bound ensemble. Ensemble docking across molecular dynamics-derived conformations further indicated that RNA binding modulates ligand-binding region accessibility without substantially altering average binding energetics. Energetic analysis of the protein-RNA interface revealed a modest reduction in interaction strength upon ligand association, suggesting that ligand binding may perturb the RNA-binding surface without disrupting the overall architecture of the complex. These results provide a system-specific computational characterization of ligand association with the UP1 interdomain region and highlight the role of conformational heterogeneity in shaping ligand-binding behavior in this protein system.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.